Skip to main content
Top
Published in: Obesity Surgery 6/2010

01-06-2010 | Clinical Research

Effect of a Single ‘Megadose’ Intramuscular Vitamin D (600,000 IU) Injection on Vitamin D Concentrations and Bone Mineral Density Following Biliopancreatic Diversion Surgery

Authors: Kristjana Einarsdóttir, David B. Preen, Timothy D. Clay, Laura Kiely, C. D’Arcy J. Holman, Leon D. Cohen

Published in: Obesity Surgery | Issue 6/2010

Login to get access

Abstract

Background

Vitamin D (VitD) deficiency is common following biliopancreatic diversion (BPD). We conducted a prospective open-label study to evaluate the efficacy of a single intramuscular injection with 600,000 IU of cholecalciferol in an arachis oil depot formulation (VitD3, Arachitol Solvay Pharmacia) as an adjunct to regular oral VitD supplementation (Citrical+D) for a period of 12 months following BPD surgery.

Methods

Some 29 patients who had undergone BPD during 2000–2005 were recruited and received a single injection of 600,000 IU of cholecalciferol. Venous blood VitD, parathyroid hormone (PTH), alkaline phosphatase (ALP), ionised calcium and urinary N-telopeptide (NTX) were assessed at baseline and at 1.5, 3, 6, 9 and 12 months post-injection. Bone mineral density (BMD) was determined at baseline and 12 months post-injection.

Results

VitD concentrations (mean ± SD) were significantly increased from baseline values (61.5 ± 18.8 nmol/L) at 1.5 months (92.4 ± 21.5, p < 0.001), 3 months (100.5 ± 24.4, p < 0.001) and 6 months (79.1 ± 20.9, p = 0.014) post-injection, with non-significant elevations at 9 months (73.3 ± 15.1, p = 0.248) and 12 months (73.4 ± 17.3, p = 0.278). The proportion of patients with ‘normalised’ VitD levels was significantly higher at all post-injection time points (range, 93–100%) compared with baseline (71.4%; p < 0.01). Ionised calcium and ALP remained within normal levels at baseline and all follow-up time points, although ionised calcium decreased by 3.4% (p = 0.015) and ALP increased by 14.6% (p = 0.021) at 12 months compared with baseline. No significant change in PTH, NTX or BMD was observed.

Conclusions

Intramuscular cholecalciferol injection, as an adjunct to oral supplementation, appears a safe and effective method to increase and maintain VitD levels after BPD.
Literature
1.
2.
go back to reference Lagace M, Marceau P, Marceau S, et al. Biliopancreatic diversion with a new type of gastrectomy: some previous conclusions revisited. Obes Surg. 1995;5:411–8.CrossRefPubMed Lagace M, Marceau P, Marceau S, et al. Biliopancreatic diversion with a new type of gastrectomy: some previous conclusions revisited. Obes Surg. 1995;5:411–8.CrossRefPubMed
3.
go back to reference Scopinaro N, Gianetta E, Adami GF, et al. Biliopancreatic diversion for obesity at eighteen years. Surgery. 1996;119:261–8.CrossRefPubMed Scopinaro N, Gianetta E, Adami GF, et al. Biliopancreatic diversion for obesity at eighteen years. Surgery. 1996;119:261–8.CrossRefPubMed
4.
go back to reference Slater GH, Ren CJ, Siegel N, et al. Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery. J Gastrointest Surg. 2004;8:48–55. discussion 4-5.CrossRefPubMed Slater GH, Ren CJ, Siegel N, et al. Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery. J Gastrointest Surg. 2004;8:48–55. discussion 4-5.CrossRefPubMed
5.
go back to reference Compston JE, Vedi S, Gianetta E, et al. Bone histomorphometry and vitamin D status after biliopancreatic bypass for obesity. Gastroenterology. 1984;87:350–6.PubMed Compston JE, Vedi S, Gianetta E, et al. Bone histomorphometry and vitamin D status after biliopancreatic bypass for obesity. Gastroenterology. 1984;87:350–6.PubMed
6.
go back to reference Johnson JM, Maher JW, Samuel I, et al. Effects of gastric bypass procedures on bone mineral density, calcium, parathyroid hormone, and vitamin D. J Gastrointest Surg. 2005;9:1106–10. discussion 10-1.CrossRefPubMed Johnson JM, Maher JW, Samuel I, et al. Effects of gastric bypass procedures on bone mineral density, calcium, parathyroid hormone, and vitamin D. J Gastrointest Surg. 2005;9:1106–10. discussion 10-1.CrossRefPubMed
7.
go back to reference Marceau P, Biron S, Lebel S, et al. Does bone change after biliopancreatic diversion? J Gastrointest Surg. 2002;6:690–8.CrossRefPubMed Marceau P, Biron S, Lebel S, et al. Does bone change after biliopancreatic diversion? J Gastrointest Surg. 2002;6:690–8.CrossRefPubMed
8.
go back to reference Newbury L, Dolan K, Hatzifotis M, et al. Calcium and vitamin D depletion and elevated parathyroid hormone following biliopancreatic diversion. Obes Surg. 2003;13:893–5.CrossRefPubMed Newbury L, Dolan K, Hatzifotis M, et al. Calcium and vitamin D depletion and elevated parathyroid hormone following biliopancreatic diversion. Obes Surg. 2003;13:893–5.CrossRefPubMed
9.
go back to reference Brolin RE, Leung M. Survey of vitamin and mineral supplementation after gastric bypass and biliopancreatic diversion for morbid obesity. Obes Surg. 1999;9:150–4.CrossRefPubMed Brolin RE, Leung M. Survey of vitamin and mineral supplementation after gastric bypass and biliopancreatic diversion for morbid obesity. Obes Surg. 1999;9:150–4.CrossRefPubMed
10.
go back to reference Goldner WS, O'Dorisio TM, Dillon JS, et al. Severe metabolic bone disease as a long-term complication of obesity surgery. Obes Surg. 2002;12:685–92.CrossRefPubMed Goldner WS, O'Dorisio TM, Dillon JS, et al. Severe metabolic bone disease as a long-term complication of obesity surgery. Obes Surg. 2002;12:685–92.CrossRefPubMed
11.
go back to reference Adams JS, Kantorovich V, Wu C, et al. Resolution of vitamin D insufficiency in osteopenic patients results in rapid recovery of bone mineral density. J Clin Endocrinol Metab. 1999;84:2729–30.CrossRefPubMed Adams JS, Kantorovich V, Wu C, et al. Resolution of vitamin D insufficiency in osteopenic patients results in rapid recovery of bone mineral density. J Clin Endocrinol Metab. 1999;84:2729–30.CrossRefPubMed
12.
go back to reference Diamond TH, Ho KW, Rohl PG, et al. Annual intramuscular injection of a megadose of cholecalciferol for treatment of vitamin D deficiency: efficacy and safety data. Med J Aust. 2005;183:10–2.PubMed Diamond TH, Ho KW, Rohl PG, et al. Annual intramuscular injection of a megadose of cholecalciferol for treatment of vitamin D deficiency: efficacy and safety data. Med J Aust. 2005;183:10–2.PubMed
13.
go back to reference Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr. 1999;69:842–56.PubMed Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr. 1999;69:842–56.PubMed
14.
go back to reference Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev. 2001;22:477–501.CrossRefPubMed Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev. 2001;22:477–501.CrossRefPubMed
15.
go back to reference Ensminger E, Ensminger M, Konlande J, et al. Vitamin D. In: The concise encyclopedia of foods and nutrition. Florida: CRC Press; 1995. pp. 1091–3. Ensminger E, Ensminger M, Konlande J, et al. Vitamin D. In: The concise encyclopedia of foods and nutrition. Florida: CRC Press; 1995. pp. 1091–3.
16.
go back to reference Shoback D, Marcus R, Bikle D. Metabolic bone disease (chapter 8). In: Greenspan F, Gardner D, editors. Basic and clinical endocrinology. McGraw-Hill; 2004. Shoback D, Marcus R, Bikle D. Metabolic bone disease (chapter 8). In: Greenspan F, Gardner D, editors. Basic and clinical endocrinology. McGraw-Hill; 2004.
17.
go back to reference de Luis DA, Pacheco D, Izaola O, et al. Clinical results and nutritional consequences of biliopancreatic diversion: three years of follow-up. Ann Nutr Metab. 2008;53:234–9.CrossRefPubMed de Luis DA, Pacheco D, Izaola O, et al. Clinical results and nutritional consequences of biliopancreatic diversion: three years of follow-up. Ann Nutr Metab. 2008;53:234–9.CrossRefPubMed
18.
go back to reference Lozano O, Garcia-Diaz JD, Cancer E, et al. Phosphocalcic metabolism after biliopancreatic diversion. Obes Surg. 2007;17:642–8.CrossRefPubMed Lozano O, Garcia-Diaz JD, Cancer E, et al. Phosphocalcic metabolism after biliopancreatic diversion. Obes Surg. 2007;17:642–8.CrossRefPubMed
19.
go back to reference Moreiro J, Ruiz O, Perez G, et al. Parathyroid hormone and bone marker levels in patients with morbid obesity before and after biliopancreatic diversion. Obes Surg. 2007;17:348–54.CrossRefPubMed Moreiro J, Ruiz O, Perez G, et al. Parathyroid hormone and bone marker levels in patients with morbid obesity before and after biliopancreatic diversion. Obes Surg. 2007;17:348–54.CrossRefPubMed
20.
go back to reference Larrad-Jimenez A, Diaz-Guerra CS, de Cuadros Borrajo P. Short-, mid- and long-term results of Larrad biliopancreatic diversion. Obes Surg. 2007;17:202–10.CrossRefPubMed Larrad-Jimenez A, Diaz-Guerra CS, de Cuadros Borrajo P. Short-, mid- and long-term results of Larrad biliopancreatic diversion. Obes Surg. 2007;17:202–10.CrossRefPubMed
21.
go back to reference Compston JE, Vedi S, Ledger JE, et al. Vitamin D status and bone histomorphometry in gross obesity. Am J Clin Nutr. 1981;34:2359–63.PubMed Compston JE, Vedi S, Ledger JE, et al. Vitamin D status and bone histomorphometry in gross obesity. Am J Clin Nutr. 1981;34:2359–63.PubMed
22.
go back to reference Ybarra J, Sanchez-Hernandez J, Gich I, et al. Unchanged hypovitaminosis D and secondary hyperparathyroidism in morbid obesity after bariatric surgery. Obes Surg. 2005;15:330–5.CrossRefPubMed Ybarra J, Sanchez-Hernandez J, Gich I, et al. Unchanged hypovitaminosis D and secondary hyperparathyroidism in morbid obesity after bariatric surgery. Obes Surg. 2005;15:330–5.CrossRefPubMed
23.
go back to reference Herrmann M, Seibel MJ. The amino- and carboxyterminal cross-linked telopeptides of collagen type I, NTX-I and CTX-I: a comparative review. Clin Chim Acta. 2008;393:57–75.CrossRefPubMed Herrmann M, Seibel MJ. The amino- and carboxyterminal cross-linked telopeptides of collagen type I, NTX-I and CTX-I: a comparative review. Clin Chim Acta. 2008;393:57–75.CrossRefPubMed
24.
go back to reference Seeman E. Invited review: pathogenesis of osteoporosis. J Appl Physiol. 2003;95:2142–51.PubMed Seeman E. Invited review: pathogenesis of osteoporosis. J Appl Physiol. 2003;95:2142–51.PubMed
25.
go back to reference Samanek AJ, Croager EJ, Gies P, et al. Estimates of beneficial and harmful sun exposure times during the year for major Australian population centres. Med J Aust. 2006;184:338–41.PubMed Samanek AJ, Croager EJ, Gies P, et al. Estimates of beneficial and harmful sun exposure times during the year for major Australian population centres. Med J Aust. 2006;184:338–41.PubMed
Metadata
Title
Effect of a Single ‘Megadose’ Intramuscular Vitamin D (600,000 IU) Injection on Vitamin D Concentrations and Bone Mineral Density Following Biliopancreatic Diversion Surgery
Authors
Kristjana Einarsdóttir
David B. Preen
Timothy D. Clay
Laura Kiely
C. D’Arcy J. Holman
Leon D. Cohen
Publication date
01-06-2010
Publisher
Springer-Verlag
Published in
Obesity Surgery / Issue 6/2010
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-009-0024-3

Other articles of this Issue 6/2010

Obesity Surgery 6/2010 Go to the issue